TLQP-30 is a VGF peptide.
TLQP-30 is a biologically active peptide derived from the C-terminal region of the VGF nerve growth factor inducible protein. As a member of the VGF-derived peptide family, TLQP-30 has garnered significant attention in neurobiology and metabolic research due to its modulatory effects on cellular signaling pathways. Its presence in various tissues, including the central nervous system and peripheral organs, underscores its multifaceted physiological relevance. Researchers value TLQP-30 for its ability to engage in neuropeptide signaling, interact with specific G protein-coupled receptors, and influence a range of cellular processes, making it a compelling tool for studying peptide-mediated mechanisms in both fundamental and applied contexts.
Neurobiological research: TLQP-30 is widely employed in studies investigating the regulation of neuronal activity and synaptic plasticity. Its capacity to modulate neurotransmitter release and affect neuronal excitability provides a valuable experimental avenue for elucidating the molecular underpinnings of neuropeptide function. Researchers utilize this peptide to probe the roles of VGF-derived fragments in neural circuitry, exploring how they influence behaviors related to learning, memory, and stress response. The peptide's selective interaction with neural receptors allows for targeted investigation of signaling cascades relevant to brain physiology and pathology.
Metabolic regulation studies: The peptide has been instrumental in advancing our understanding of energy homeostasis and metabolic control. TLQP-30 is known to participate in the modulation of appetite, energy expenditure, and lipid metabolism through its signaling actions in hypothalamic and peripheral tissues. Experimental models have leveraged its activity to dissect the pathways governing adipocyte function and metabolic adaptation, providing insight into the intricate balance of neuroendocrine and metabolic networks. As such, it serves as a robust molecular probe for exploring peptide-mediated regulation of metabolic processes.
Peptide receptor characterization: TLQP-30 is frequently used as a ligand in the identification and functional analysis of its cognate G protein-coupled receptors, such as C3a receptor 1 (C3aR1). By applying the peptide in receptor binding assays and downstream signaling studies, researchers can delineate receptor specificity, affinity, and activation mechanisms. This approach enables the mapping of peptide-receptor interactions and supports the development of new tools for modulating receptor activity in vitro and in vivo. Such receptor-focused investigations are crucial for expanding the knowledge base surrounding neuropeptide signaling systems.
Signal transduction pathway analysis: The peptide's ability to activate intracellular signaling cascades makes it a valuable tool for dissecting molecular pathways in both neuronal and non-neuronal cells. Experimental applications often involve monitoring changes in second messenger levels, kinase activity, or gene expression in response to peptide stimulation. These studies facilitate a deeper understanding of how VGF-derived peptides like TLQP-30 orchestrate complex cellular responses, contributing to the broader field of signal transduction research and the identification of novel regulatory nodes within cellular networks.
Peptide structure-function studies: TLQP-30 is also utilized in structure-activity relationship (SAR) investigations to determine the critical amino acid residues responsible for its biological activity. By synthesizing analogs or introducing targeted modifications, researchers can assess how structural variations impact receptor binding, signaling potency, and physiological outcomes. These studies not only inform the design of more selective or potent peptide analogs but also enhance the mechanistic understanding of VGF-derived peptide function, supporting the rational development of research tools for neurobiology and metabolism.
1. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More